A new drug discovery approach, which essentially reverses the process of drug compound screening promises a increased efficiency in drug discovery whilst keeping costs down to a minimum.

BioPharma-Reporter.com (http://www.biopharma-reporter.com/news/ng.asp?n=67967-greentech-screening-alzheimer-s)